Close Menu

NEW YORK – Bruker on Friday released final Q4 and full year 2020 results showing Q4 revenues up 8 percent year over year and full-year revenues up 9 percent.

The company reported preliminary revenues on Feb. 18 but postponed reporting of final results due to an allegation regarding accounting irregularities. After an investigation the company found that its financial results, including revenue and operating income, were unchanged from those in its preliminary report.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nearly 30,000 COVID-19 tests the UK sent to the US came back as void, according to the Telegraph.

Black principal investigators receive less favorable application scores when seeking US National Institutes of Health grants, the Chronicle of Higher Education reports.

New Scientist reports that both RNA and DNA may have been involved in the emergence of life on Earth.

In Nature this week: new Sperm-seq method enables crossover analysis, tumor-informed detection approach for minimal residual disease, and more.